Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
GEN's Annual Top 20 Molecular Millionaires
- Genetic Engineering News is pleased to present the 2006 version of GEN’s Molecular Millionaires. This is our annual listing of doctoral-degree-holding individuals who have made millions through ownership of biotechnology and pharmaceutical stocks. You will no doubt notice a change from the past. Instead of just listing our Molecular ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.